Role of Antiplatelet Therapies in Preventing Atherothrombosis

作者: Mohamed Z Khalil

DOI: 10.4172/2329-8790.1000108

关键词: CardiologyMyocardial infarctionStrokeHemostasisIschemiaAcute coronary syndromeInternal medicineSurgeryBlood flowMedicineCerebral infarctionPlatelet

摘要: Platelets exhibit a major role in development and progression of atherothrombosis. The normal function platelets is to secure hemostasis at sites vascular injuries. Abnormal endovascular structure may result excessive platelet with consequence progressive or acute reduction lumen cessation blood flow. Despite succeeding averting bleeding, total occlusion vessel leads inevitable ischemia eventual cell death upon lack supply clinically manifesting as myocardial infarction coronary vessels, cerebral (stroke) peripheral gangrene arterial disease. Antiplatelets long have been used halt the process atherothrombosis preventing further tissue damage expense bleeding well other side effects. In this review, antiplatelets primary secondary prevention thrombotic events explored light evidence based clinical practice.

参考文章(298)
Maria Pérez-Caro, Isidro Sánchez-Garcia, BCR-ABL and Human Cancer Apoptosis, Cell Signaling, and Human Diseases. pp. 3- 34 ,(2007) , 10.1007/978-1-59745-200-7_1
Natini Jinawath, Alexis Norris-Kirby, B. Douglas Smith, Christopher D. Gocke, Denise A. Batista, Constance A. Griffin, Kathleen M. Murphy, A Rare e14a3 (b3a3) BCR-ABL Fusion Transcript in Chronic Myeloid Leukemia The Journal of Molecular Diagnostics. ,vol. 11, pp. 359- 363 ,(2009) , 10.2353/JMOLDX.2009.090008
Barlera S, Maggioni Ap, Tognoni G, Santoro E, Staszewsky L, Franzosi Mg, Latini R, Masson S, Gissi Investigators, Salio M, Labarta, Calvillo L, Tavazzi L, Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial. Heart Disease. ,vol. 2, pp. 185- 190 ,(2000)
Usman Baber, Mohammed Akhter, Annapoorna Kini, Samin K Sharma, Sharad Kothari, Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents. Journal of Invasive Cardiology. ,vol. 22, pp. 80- 83 ,(2010)
David P. Faxon, Richard W. Nesto, Antiplatelet therapy in populations at high risk of atherothrombosis. Journal of The National Medical Association. ,vol. 98, pp. 711- 721 ,(2006)
Marco Valgimigli, Gianluca Campo, Gianfranco Percoco, Monia Monti, Fabrizio Ferrari, Carlo Tumscitz, Andrea Zuffi, Federico Colombo, Moh'd Kubbajeh, Caterina Cavazza, Elisa Cangiano, Matteo Tebaldi, Monica Minarelli, Chiara Arcozzi, Antonella Scalone, Alice Frangione, Marco Borghesi, Jlenia Marchesini, Giovanni Parrinello, Roberto Ferrari, Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention American Heart Journal. ,vol. 160, pp. 804- 811 ,(2010) , 10.1016/J.AHJ.2010.07.034